Article
Pathogenic ultra-rare variants in<i>SLC6A1, SLC6A11, GAD1 and GAD2</i>are new & recurrent GABAergic loci for GGE syndromes
2025-04-04
Abstract excerpt
There is a wealth of biological evidence that supports the concept that GABAergic inhibition is causal to some genetic generalized epilepsy (GGE) syndromes. Much is known about postsynaptic GABAAR channelopathies, however, the presynaptic determinants are less well-defined such as the role of GABA transporters ( SLC6A1 / GAT1; SLC6A11 / GAT3), and GABA biosynthesis biology ( GAD1 / GAD67; GAD2 / GAD65). In respons...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7dd41750-2d50-560e-9206-a618e65ab59a
- DOI
- 10.1101/2025.04.01.24316792
